LifeTech Scientific Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LFTSF research report →
About the company
LifeTech Scientific Corporation, established in 1999 and headquartered in Shenzhen, People's Republic of China, operates as an investment holding company. Its primary focus is the development, manufacturing, and commercialization of state-of-the-art interventional medical devices specifically designed to address cardiovascular and peripheral vascular ailments. The company structures its operations across three distinct segments: Structural Heart Diseases, Peripheral Vascular Diseases, and Cardiac Pacing and Electrophysiology.
- CEO
- Yuehui Xie
- IPO
- 2021
- Employees
- 1,395
- HQ
- Shenzhen, CN
Price Chart
- Market Cap
- $1.03B
- P/E
- 40.33
- P/S
- 4.11
- P/B
- 1.70
- EV/EBITDA
- 16.67
- Div Yield
- 0.00%
- Gross Margin
- 74.40%
- Op Margin
- 13.48%
- Net Margin
- 10.79%
- ROE
- 4.06%
- ROIC
- 3.06%
- Revenue
- $1.37B · 5.07%
- Net Income
- $147.83M · -33.53%
- EPS
- $0.03 · -33.33%
- Op Income
- $175.88M
- FCF YoY
- 937.55%
- 52W High
- $0.23
- 52W Low
- $0.23
- 50D MA
- $0.23
- 200D MA
- $0.23
- Beta
- 0.32
- Avg Volume
- 64.4
Get TickerSpark's AI analysis on LFTSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LFTSF coverage
Recent articles, reports, and earnings notes.
No research on LFTSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LFTSF report →Similar companies
Peers in the same neighborhood.